Clinical Trial Update: Thalidomide to Patients With Previously Untreated Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on thalidomide in patients with previously untreated multiple myeloma; the study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED